Mary Ann Liebert, Inc., has announced the appointment of Dr. Andrei Moroz as the new Deputy Editor-in-Chief of the esteemed bimonthly journal, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. Dr. Moroz will join Dr. Cory Brooks as part of the senior editorial leadership team, bringing his expertise and vision to further advance the journal's mission.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy serves as a premier peer-reviewed platform for research rooted in hybridoma technology. With a focus on advancing the understanding of biology and immunology underlying the utility of antibodies in diagnostics and therapeutics, the journal publishes cutting-edge research on topics ranging from B cell biology to antibody engineering innovations.
Dr. Andrei Moroz, an Assistant Professor in the School of Pharmaceutical Sciences at São Paulo State University (UNESP), brings a wealth of expertise to his new role. With a PhD in Applied Cell and Structural Biology from UNESP, Dr. Moroz's research centers on tissue engineering, extracellular matrices, and monoclonal antibody production and characterization. His appointment as Deputy Editor-in-Chief underscores the journal's commitment to excellence and innovation in the field of immunodiagnosis and immunotherapy.
Click here to read the original press release.
